Skip to main content

Personality traits and hardiness as risk- and protective factors for mental distress during the COVID-19 pandemic: a Norwegian two-wave study



Several risk factors for anxious-depressive symptomatology during the COVID-19 pandemic have been established. However, few studies have examined the relationship between personality traits, hardiness, and such symptomatology during the pandemic. These constructs might serve as risk- and/or protective factors for such mental distress through the pandemic.


A sample of 5783 Norwegians responded to a survey at two time points within the first year of the pandemic. The first data collection was in April 2020 (T1) and the second in December 2020 (T2). Measures included the Ten-Item Personality-Inventory, the Revised Norwegian Dispositional Resilience Scale, and the Patient Health Questionnaire Anxiety and Depression Scale. Analyses were performed using Pearson’s correlations, multiple linear regression, and a moderation analysis.


Anxious-depressive symptomatology in early phases (T1) of the pandemic was the strongest predictor for the presence of such symptomatology 9 months after the outbreak (T2). Personality and hardiness correlated significantly with mental distress at T1 and T2. Personality traits explained 5% variance in symptoms when controlling for age, gender, solitary living, negative economic impact, and mental distress at baseline. Higher neuroticism predicted higher mental distress, whereas higher conscientiousness and extraversion predicted less mental distress. Hardiness did not explain variance in outcome beyond personality traits. Hardiness did not significantly moderate the relationship between neuroticism and mental distress.


Individuals with high levels of neuroticism had greater difficulties adapting to the circumstances of the COVID-19 pandemic and were more prone to mental distress. Contrastingly, higher conscientiousness and extraversion may have served as protective factors for mental distress during the pandemic. The current findings might aid identification of vulnerable individuals and groups. Consequently, preventive interventions could be offered to those who need it the most.

Peer Review reports


Several meta-analyses and systematic reviews have reported elevated rates of anxious-depressive symptomatology during the COVID-19 pandemic [1,2,3,4,5]. For instance, the prevalence of anxiety and depression reported by Luo and colleges [2] was 33 and 28%, respectively, while Cénat and colleges [1] found lower rates (15 and 16%, respectively). Prevalence estimates of self-reported anxiety and depression before the pandemic was 14.7% [6] and 8.1% [7], respectively. Although there are temporal and cultural differences in the referred studies, the pandemic and its consequences could appear to impact mental health. However, despite ascending prevalence of anxious-depressive symptomatology in early phases of the pandemic, rates of suicide, life satisfaction and loneliness have remained constant throughout the first year of the pandemic [8]. This suggests a complex picture of stressors and adaptive responses. Consequently, more knowledge concerning risk- and protective factors for anxious-depressive symptomatology during the pandemic is warranted.

Numerous risk factors for symptoms of anxiety and depression during the pandemic have been identified, including solitary living, lower age, pre-existing mental health problems, social isolation/quarantine, low socioeconomic status, negative economic influence, poor sleep quality, and female gender [2, 4, 5, 8, 9]. Although the Big Five personality traits [10] are involved in the etiology of anxiety and depression [11,12,13], research on personality as a risk- and protective factor for such symptoms during the COVID-19 pandemic is scarce. Preceding the pandemic, the relationships between higher neuroticism, lower conscientiousness, and higher anxiety and depression were already well established [11,12,13]. Lower extraversion was also implicated [13], although less consistently [12]. During the COVID-19 pandemic, one might expect lower neuroticism and higher conscientiousness to predict less anxious-depressive symptomatology through an inclination towards emotional stability, positive emotions, gregariousness, and self-competence [14]. The role of extraversion could be more questionable during the pandemic, as in-person social contact has been restricted.

As far as we are aware, only a handful of studies regarding personality, anxiety and depression have been conducted during the COVID-19 pandemic. Summarized, cross-sectional results have established a positive relationship between higher neuroticism and higher levels of psychological distress [15,16,17,18,19,20]. Furthermore, extraversion, agreeableness, openness, and conscientiousness are cross-sectionally associated with favorable psychological adjustment, and less anxious-depressive symptoms [15, 18]. Noticeably, neuroticism predicted more worry and risk-perception of the pandemic [17]. However, more large-scale studies exploring if and how personality traits are associated with anxious-depressive symptomatology during the COVID-19 pandemic are warranted.

As emphasized by Klein et al. [11] it is necessary to develop explanatory models of how and why personality and psychopathology are interrelated. The construct of resilience might be a central interactional mechanism between personality and psychopathology, as the protective model of resilience [21] postulates that resilience moderates the relationship between risk factors (e.g., neuroticism) and adverse outcomes (e.g., anxious-depressive symptomatology). Furthermore, a recent meta-analysis has established relationships between the Big Five personality traits and resilience [22]. Results revealed that resilience was negatively related to neuroticism and positively related to extraversion, openness, agreeableness, and conscientiousness. Moreover, studies have established positive relationships between resilience factors and well-adjusted personality profiles [23], in addition to personality clusters that corresponds to resilient self-regulation [24]. Withal, neuroticism is related to heightened stress [25, 26], and resilience is known to moderate negative outcomes of stress [21, 27]. Hence, there might be interactional effects of personality traits and resilience on mental distress.

There are several ways in which resilience can be defined and conceptualized [28,29,30]. Hardiness [31, 32] is a conceptualization of trait resilience, pertaining to “a generalized style of functioning characterized by a strong sense of commitment, control, and challenge that serves to mitigate the negative effects of stress” [33 , p. 237]. Kobasa [31] described commitment as an inclination towards active involvement in one’s activities, whereas control involves the belief in one’s ability to influence important life events. Moreover, challenge concerns a disposition towards considering changing circumstances as natural and as a chance for development and growth. Commitment is contrasted with alienation, control with powerlessness, and challenge with threat [34].

Measured with the Dispositional Resilience scale-15 (DRS-15) [35], studies have demonstrated that hardiness buffers against depressive symptoms [36], post-traumatic stress symptoms [37], and somatic and psychological symptoms [38]. Meta-analytically, hardiness is positively associated with extraversion, active coping, social support, self-efficacy [39], and negatively related to negative affectivity, neuroticism, and trait anxiety [40]. Hence, resilient individuals might cope with adverse life events by perceiving stressors as less threatening, assuming control over important outcomes in one’s life, utilizing adaptive coping strategies and social support [32, 40, 41]. Consequently, this might reduce such individuals’ risk of experiencing mental distress during adverse life events throughout the COVID-19 pandemic.

Research on hardiness during the pandemic is scarce. A cross-sectional investigation of 510 Italian emergency workers found that hardiness buffers against the effects of stress on secondary trauma [42]. However, this study did not include measures of both personality traits and hardiness, in relation to mental distress. To the best of our knowledge, no such studies have yet been issued in the context of the COVID-19 pandemic.

Thus, the aim of the current study is to examine hardiness, personality traits, and their relationship to mental distress in a heterogeneous Norwegian sample, during two phases of the COVID-19 pandemic. More specifically, the study had two aims. First, to study the predictive validity of hardiness and personality traits for mental distress. Second, to study whether hardiness moderated the hypothesized relationship between neuroticism and mental distress. First, we hypothesized that neuroticism would predict more mental distress. Second, hardiness was hypothesized to predict lower levels of mental distress. Third, based on the established relationships between the Big Five personality traits and resilience, as well as the protective resilience-model [21], hardiness was hypothesized to moderate the relationship between neuroticism and anxious-depressive symptomatology. We expected hardiness to reduce the hypothesized positive relationship between neuroticism and such symptoms.


Participants and procedure

This study is a part of the BryDeg2020-project [43], which is a longitudinal survey study examining mental health in the Norwegian population during the COVID-19 pandemic. The study obtained ethical approval from the Regional Committee for Medical and Health Research Ethics in Northern Norway (REK Nord, reference number 123324), and was launched shortly after the societal lockdown in Norway (12th of March 2020). Data was collected in two waves, using online surveys. Wave 1 (T1) lasted from 1st of April to 2nd of June 2020 (Most data collected in April [87.2%]). Wave 2 (T2) was carried out between December 1st and 22nd 2020. Recruitment to T1 was accomplished as several organizations contributed by sharing the survey invitation with their members. This included most Universities and Colleges in Norway, the national student association, the Norwegian Council for Mental Health, and one of Norway’s largest hospital trusts. Furthermore, the study was advertised in social media, and the Norwegian Broadcasting Corporation encouraged the public to participate. At T1, participants were asked to take part in the T2-data collection. Follow-up questionnaires were sent to those who agreed (n = 13,410, 69% of the original sample).

Informed consent was obtained from all participants before inclusion. At T1 the sample consisted of 19,372 participants, of whom 6017 (31.06% of the sample at T1) responded to the follow-up at T2. The study has an overrepresentation of women and young adults with high levels of education compared with the general Norwegian population [9]. Mental distress was marginally higher in subjects participating in T1 only, compared to those who participated in both waves and were included in this study (t = 4.95, p < .001, d = 0.08; see next paragraph). The groups’ hardiness-scores did not differ (t = − 1.44, p = 0.15, d = − 0.02). Furthermore, as noted by Unnarsdóttir et al. [44], the dropouts were characterized by lower age, student status, fewer with a completed bachelor’s degree, and there were more men.

The analyses in the current study are based on data from subjects who participated at both at T1 and T2. Of the participants who responded at both waves, 193 (3.21%) had missing data on one or more of the utilized measures. Overall, there were 266 (0.74%) values missing. As missing rates below 5% are considered inconsequential [45], participants with missing data were trimmed list-wise. Consequently, 106, 41, and 46 cases were deleted from the hardiness inventory, the depression scale, and the anxiety measure, respectively. Participants with an unreliable response style (n = 41) were also trimmed list-wise. Accordingly, the final sample consisted of 5783 participants. Table 1 displays sample demographics at both times of measurement.

Table 1 Sample demographics and descriptive statistics of included measures (N = 5783)


Personality traits were measured at T2 only, utilizing the Ten-Item Personality-Inventory (TIPI) [46]. The TIPI assesses the personality traits in Costa & McCrae’s Five-Factor Model [10], using two items per trait. Each item is scored on a 7-point scale (ranging from 1 = “strongly disagree” to 7 = “strongly agree”). The TIPI has demonstrated poor to good test-retest reliability (.52 to .83) dependent on the trait measured, and self-other agreement estimates ranges from .42 to .61 [46, 47], The instrument has adequate structure validity, convergent validity (.36 to .61 with the Revised NEO Personality Inventory) [14], and predictive validity [46, 47]. Reported Cronbach’s α coefficients ranges from .50 to .57 on average across traits [46,47,48]. In the current study, Cronbach’s α coefficients were .79 for extraversion, .69 for conscientiousness, .72 for neuroticism, .45 for openness, and .35 for agreeableness. The TIPI measures emotional stability (the opposite pole of neuroticism). However, to aid interpretability and comparison of results with similar studies, the emotional stability-variable was reversed to represent neuroticism.

Hardiness was measured with the Revised Norwegian Dispositional Resilience Scale (DRS-15-R) [33] at T1 only. The DRS-15-R is a valid and reliable measure of personal characteristics indicative of efficacious psychological adaption in the face of adverse life events [33]. The 15-item self-report questionnaire assesses three facets of hardiness (commitment, control, and challenge) on a Likert scale ranging from 0 (“not true”) to 3 (“completely true”). The DRS-15-R was measured at T1. In the current study, the overall Cronbach’s α value was .82, whereas α values were .83, .74 and .72 for commitment, control, and challenge, respectively.

As there is evidence for related underlying psychological constructs of anxiety and depression, as well as high comorbidity between the two disorder categories [49], the Patient Health Questionnaire Anxiety and Depression Scale (PHQ-ADS) [49] was used to assess mental distress at both times of measurement. The PHQ-ADS is a joint measure for symptoms of anxiety and depression, which is computed by summing the scores of the Patient Health Questionnaire-9 (PHQ-9) [50] and the Generalized Anxiety Disorder 7 (GAD-7) [51]. The scores of the PHQ-ADS range from 0 to 48, with greater scores indicating more severe symptoms. Scores of 0–9, 10–19, 20–29, and 30–48 are indicative of minimal, mild, moderate, and severe anxious-depressive symptomatology, respectively [49]. The PHQ-ADS is a reliable and valid measure with satisfactory psychometric properties [49, 52]. In the current study, Cronbach’s α values were .94 at both T1 and T2.

Housing situation was reported on a 5-point scale (1 = solitary living, 2 = with one or both parents, 3 = with roommates, 4 = with partner/wife/husband, 5 = other). Economic impact of the pandemic was similarly reported (1 = very negative, 2 = somewhat negative, 3 = no change, 4 = somewhat positive, 5 = very positive). Alcohol consumption and exercise were measured as two separate items, utilizing 5-point scales (from 1 = significantly reduced, to 5 = significantly increased). These measures were dichotomized, specifying whether subjects were living alone (score = 1) or not (score = 2–5), had increased alcohol consumption (score = 4 and 5) or not (score = 1–3), exercised less (score = 1 and 2) or not (score = 3–5), and experienced negative economic impact (score = 1 and 2) or not (score = 3–5). Participants reported changes in job status (1 = yes [on leave/lost job], 2 = no changes). Self-reported psychiatric disorder (and treatment) was measured as 0 = not received treatment, 1 = previously psychiatric treatment, and 2 = currently in treatment for psychiatric treatment. Participants that had received treatment were then asked to specify for which disorder. The reported variable grouped together scores 1 and 2, as to represent individuals who currently, or previously, received treatment for a psychiatric disorder.

Statistical analyses

Pearson’s correlations were utilized to provide correlations of all study variables. Furthermore, hierarchical regression was applied to investigate hypotheses 1 and 2. The model controlled for age and gender on step 1, self-reported solitary living on step 2, self-reported negative economic impact on step 3, and symptoms at baseline on step 4. Personality traits were entered at step 5. Hardiness was entered at step 6. To test hypothesis 3, we administered an additive multiple moderation analysis, based on the least squares’ method. The model utilized the control variables from the regression analysis as covariates. To aid interpretability and prevent multicollinearity, all independent variables were mean centered before analyzed with inference statistics [53]. Dummy coding of the three-leveled gender variable was applied before entering the variable into the regression- and moderation analyses. The variable “female” was coded as 0 = non-female (i.e., male and other gender) and 1 = female. The variable “other gender” was coded as 0 = non-other (i.e., male and female gender) and 1 = other gender. To ensure that the results were uninfluenced by the trimming procedures, the correlation and regression analyses were repeated using multiple imputation. The imputation was performed using the multiple imputation algorithm with 5 simulations in IBM SPSS statistics version 26.


Table 1 displays descriptive statistics of the utilized measures. Levels of mental distress (PHQ-ADS) increased marginally from T1 to T2 (t = − 8.55, p < .001, d = − 0.08). Drawing on Kroenke and colleagues’ [49] cut-off scores, the prevalence of minimal, mild, moderate, and severe levels of anxious-depressive symptomatology at T1 was 41.74%, 30.69%, 15.91% and 11.65%, respectively. At T2, the prevalence estimate of anxious-depressive symptomatology was 37.45% (minimal), 31.92% (mild), 18.59% (moderate), and 12.04% (severe).

Associations between hardiness, personality and symptoms of anxiety and depression

Table 2 is a correlation matrix with the present study’s variables. Hardiness and its subscales (measured at T1) were significant and negatively correlated with mental distress at both waves, as were extraversion, agreeableness, conscientiousness, and openness (measured at T2). There was a significant and positive relationship between neuroticism and mental distress at both waves. Results were essentially identical, with no differences in significance levels and merely negligible differences in a few correlation coefficients, when the correlation analysis was based on data imputed with multiple imputation (N = 5969; see supplemental Table 1).

Table 2 Correlations between hardiness, personality traits, and mental distress (N = 5783)

Predicting anxious-depressive symptomatology using personality traits and hardiness

Table 3 presents the results of the multiple linear regression with PHQ-ADS at T2 as the outcome variable. Overall, the model explained 61% of the variance in symptomatology. Age and gender, solitary living, negative economic impact during the pandemic, symptoms at baseline, and personality traits all significantly explained variance in outcome. Personality traits uniquely explained 5% of the variance in symptoms, whereas hardiness did not significantly add to the explained variance. All individual variables were significant predictors of mental distress in the final step of the equation, except from female gender, other gender, openness, and hardiness. More specifically, greater age prospectively predicted less symptoms, whereas solitary living and negative economic impact both predicted more symptoms, cross-sectionally. Withal, higher anxious-depressive symptomatology at baseline was the strongest predictor of more symptoms at T2. Cross-sectionally, higher neuroticism predicted more mental distress, whereas higher conscientiousness, agreeableness, and extraversion predicted less mental distress.

Table 3 Predicting mental distress (T2) using personality traits and hardiness (N = 5783)

The Durbin-Watson statistic was 1.99 indicating nonappearance of autocorrelation. No issues with multicollinearity were found, as VIF values ranged from 1.03 to 1.91 Results were essentially identical, with no differences in significance levels, when the regression analysis was based on data imputed with multiple imputation (N = 5969; se supplemental Table 2).

Hardiness as a moderator of the relationship between neuroticism and mental distress

Table 4 displays the results of the association between neuroticism and anxious-depressive symptomatology, moderated by hardiness. The overall model explained 61% of the variance in symptoms (F [13, 5769] = 746.06, p < .001, R2 = .61). The individual predictors and covariates neuroticism, age, solitary living, negative economic impact, mental distress at baseline, conscientiousness, agreeableness, and extraversion significantly predicted mental distress. The interactional effect between neuroticism and hardiness on mental distress was not significant. Addition of the interaction between neuroticism and hardiness did not significantly explain variance in mental distress (F [1, 5769] = .45, p = .500, ΔR2 = .000).

Table 4 Model coefficients in the moderation analysis (N = 5783)


The present study set out to investigate if personality traits and hardiness could represent risk- and protective factors for mental distress during the COVID-19 pandemic. Specifically, the predictive validity of personality traits and hardiness for mental distress were investigated. A moderation analysis was also applied, with the intent to examine if hardiness buffered the effect of neuroticism on mental distress.

Regarding personality, all traits were significant and negatively correlated with mental distress at both T1 and T2, except for neuroticism which was significant and positively correlated with mental distress at both times of measurement. Personality traits at T2 uniquely explained 5% of the variance in symptoms at T2 when controlling for age, gender, solitary living, negative economic impact, and mental distress at baseline. Neuroticism constituted a risk factor for mental distress. Contrastingly, conscientiousness, extraversion and agreeableness were implicated as protective factors. Openness was not significantly associated with mental distress. Contrary to the study’s third hypothesis, the results did not find evidence for hardiness moderating the association between neuroticism and mental distress.

These results corroborate the existing literature of personality traits’ association to anxious-depressive symptomatology [11,12,13] in the context of the COVID-19 pandemic. As presented, neuroticism is most consistently related to such symptoms. Rumination and worry are described as cognitive manifestations of neuroticism [54, 55], and are implicated in the etiology of anxious and depressive disorders [56]. High neuroticism may result in an inclination towards worry and rumination, which in turn might contribute to presence of mental distress [54,55,56]. Alternatively, one might underscore the fact that the pandemic has involved a myriad of negative consequences and uncertainty on multiple levels, with impact on many people’s lives. Intolerance of uncertainty and pessimistic inferential style are known cognitive risk factors for anxiety and depression, respectively [57]. Hence, one might argue that individuals possessing one or both cognitive risk factors, in addition to a high score on neuroticism, might be especially vulnerable to worry and rumination, and thus anxious-depressive symptomatology, throughout uncertain and distressing times of the COVID-19 pandemic.

Pertaining to hardiness, the current results revealed that all three hardiness constructs were significant and negatively correlated with mental distress at both times of measurement. However, hardiness did not explain variance in outcome above and beyond personality traits. Furthermore, when treated as a single predictor in the last step of the regression, hardiness was not significant. This contradicts Eschleman and colleagues’ [40] results, which established significant, negative relationships between hardiness and depression and anxiety. Thus, the current findings accentuate the importance of controlling for personality traits when examining the predictive validity of hardiness.

As a theoretical construct, hardiness is postulated to protect against negative health-effects of stress. Thus, several studies have included some form of stress-measure [36,37,38] as an interactional variable. Consequently, the present study’s lack of a stress measure might explain why hardiness was insignificant in the regression- and moderation models. In congruence with this line of reasoning, Havnen et al. [27] found that resilience (using a different measure than the DRS-15-R) diminished the impact of stress on anxious-depressive symptoms during the COVID-19 pandemic. Other factors that might contribute to the contrasting findings of the current study and the study of Havnen et al. [27], might be different operationalizations of resilience, differences in sample sizes and sample characteristics, and/or that the current study controlled for personality traits.

This study’s final hypothesis was falsified, as hardiness did not significantly moderate the positive association between neuroticism and mental distress. The premises in the previous discussion of the lack of a stress measure in relation to hardiness, might also apply to explain the results of the moderation model. Consequently, we cannot rule out that hardiness may have significantly moderated the association between stress and mental distress during the pandemic. Moreover, very few subjects (n = 60) scored high (≥1 SD above M) on neuroticism and hardiness simultaneously. Similarly, only 39 participants scored low (≤1 SD below M) on both hardiness and neuroticism simultaneously. The negative correlation coefficients between hardiness and neuroticism (table 2) also indicates this tendency. This might aid explanation of the insignificant interactional effect in the moderation model, as individuals with high neuroticism seldomly had higher hardiness to buffer against symptoms.

Finally, the present study corroborates risk factors of anxious-depressive symptomatology in the existing COVID-19-literature (e.g., 2, 4, 5, 8), as the results demonstrated that young age, self-reported solitary living, and negative economic impact were significant predictors of mental distress. As highlighted by Brand [58], economic concerns are likely to cause mental distress. The current results validate this notion. Additionally, mental distress at T1 was the strongest predictor of mental distress at T2, corroborating the notion regarding stability in symptoms and the exposed situation of vulnerable groups during the COVID-19 pandemic. Moreover, this study corroborates the evidence implicating solitary living as a risk factor for mental distress during COVID-19 pandemic. Although the current results cannot explain why such living condition constitutes a risk factor, one might argue that for some solitary living contributes to unfulfilled social needs, less social support, and increased perceived social isolation during the COVID-19-related lockdown.


The current study has limitations that warrant consideration. First, utilizing convenience sampling limits the generalizability of the results. So does the low mean age, and overrepresentation of students and women in the sample. Second, the sampling procedures prohibits estimation of response rates, as the number of people invited to participate is unknown. Third, as brevity was a priority, the TIPI was applied to measure personality traits. However, the TIPI is psychometrically inferior to more comprehensive standard measures of personality traits. The internal consistency estimates of the TIPI were especially weak for two personality traits (openness and agreeableness) which could be expected when measuring traits using only two items. Fourth, individuals concerned with the pandemic might be more inclined towards participation. Hence, this study may be vulnerable to a certain degree of response bias. Fifth, attrition rates from T1 to T2 were high, which could inflate the risk of attritional bias. However, only minor differences in demographic variables and scores of mental distress were found between the two samples. Thus, the risk of attritional bias is minimal, although it cannot be completely ruled out. Sixth, although the TIPI and the DRS-15-R measures constructs on a dispositional level, one might argue that all predictor variables should have been measured at both times of measurement, resulting in a purely longitudinal study design. Seventh, there are some concerns regarding the discriminant validity between hardiness and personality traits, as both are dispositional variables. As accentuated by Oshio et al. [22], future studies should indeed resolve whether trait resilience (e.g., hardiness) should be regarded as a personality characteristic or not. Moreover, future research investigating the predictive capacity of hardiness should control for personality traits. Finally, the measures of alcohol consumption, exercise, job status, living conditions, psychiatric disorder, and economic impact were unstandardized, unvalidated self-report measures.


This study has identified some potential predictors of mental distress 9 months after the outbreak of the COVID-19 pandemic in Norway. Symptoms at baseline, solitary living, perceived negative economic impact and neuroticism emerged as potential risk factors for mental distress. Conscientiousness and extraversion were the most pronounced protective factors for mental distress.

The current findings could aid identification of vulnerable groups and individuals (i.e., groups and individuals who possess one or more of the identified risk factors, and few or none of the identified protective factors) throughout the pandemic. These groups/individuals might profit from various preventive measures, at multiple levels of intervention. Such preventive interventions might include (non-exhaustive list) universal, selective and/or indicative psychosocial, educational, occupational, recreational and/or economic measures. Interventions could be delivered at individual-, group-, and/or population-level. Individuals with abnormal levels of anxious-depressive symptomatology, should receive the appropriate, evidence-based biopsychosocial treatment. The National Institute for Health and Care Excellence (NICE) recommends cognitive behavioral therapy in the treatment of depression and anxiety [59, 60].

Availability of data and materials

The dataset used and analyzed during the current study is available from the corresponding author on reasonable request.



Beck Depression Inventory

COVID-19 pandemic:

The pandemic caused by the virus entitled Severe acute respiratory syndrome coronavirus type 2


Dispositional Resilience scale-15


Revised Norwegian Dispositional Resilience Scale


Generalized Anxiety Disorder 7


Patient Health Questionnaire-9


Patient Health Questionnaire Anxiety and Depression Scale


First time of measurement


Second time of measurement


Ten-Item Personality-Inventory


Variance inflation factor


  1. Cénat JM, Blais-Rochette C, Kokou-Kpolou CK, Noorishad P-G, Mukunzi JN, McIntee S-E, et al. Prevalence of symptoms of depression, anxiety, insomnia, posttraumatic stress disorder, and psychological distress among populations affected by the COVID-19 pandemic: A systematic review and meta-analysis. Psychiatry Res. 2021;295:113599.

    CAS  Article  PubMed  Google Scholar 

  2. Luo M, Guo L, Yu M, Wang H. The psychological and mental impact of coronavirus disease 2019 (COVID-19) on medical staff and general public–A systematic review and meta-analysis. Psychiatry Res. 2020;113190.

  3. Salari N, Hosseinian-Far A, Jalali R, Vaisi-Raygani A, Rasoulpoor S, Mohammadi M, et al. Prevalence of stress, anxiety, depression among the general population during the COVID-19 pandemic: a systematic review and meta-analysis. Glob Health. 2020;16(1):1–11.

    Article  Google Scholar 

  4. Vindegaard N, Benros ME. COVID-19 pandemic and mental health consequences: Systematic review of the current evidence. Brain Behav Immun. 2020;89:531–42.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  5. Xiong J, Lipsitz O, Nasri F, Lui LM, Gill H, Phan L, et al. Impact of COVID-19 pandemic on mental health in the general population: A systematic review. J Affect Disord. 2020;277:55–64.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  6. Johansson R, Carlbring P, Heedman Å, Paxling B, Andersson G. Depression, anxiety and their comorbidity in the Swedish general population: point prevalence and the effect on health-related quality of life. PeerJ. 2013;1:e98.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Dahl AA, Grotmol KS, Hjermstad MJ, Kiserud CE, Loge JH. Norwegian reference data on the Fatigue Questionnaire and the Patient Health Questionnaire-9 and their interrelationship. Ann General Psychiatry. 2020;19(1):1–9.

    Article  Google Scholar 

  8. Aknin LB, De Neve JE, Dunn WE, Fancourt DE, Goldberg E, Helliwell JF, et al. Mental Health During the First Year of the COVID-19 Pandemic: A Review and Recommendations for Moving Forward. Perspect Psychol Sci. 2021:accepted, pre-edited.

  9. Hagen K, Solem S, Stavrum AK, Eid J, Kvale G, Samdal O, et al. Mental health symptoms during the first months of the COVID-19 outbreak in Norway: A cross-sectional survey study. Scand J Public Health. 2021.

  10. Costa PTJ, McCrae RR. Four ways five factors are basic. Pers Individ Differ. 1992;13(6):653–65.

    Article  Google Scholar 

  11. Klein DN, Kotov R, Bufferd SJ. Personality and depression: explanatory models and review of the evidence. Annu Rev Clin Psychol. 2011;7:269–95.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Kotov R, Gamez W, Schmidt F, Watson D. Linking “big” personality traits to anxiety, depressive, and substance use disorders: a meta-analysis. Psychol Bull. 2010;136(5):768–821.

    Article  PubMed  Google Scholar 

  13. Malouff JM, Thorsteinsson EB, Schutte NS. The relationship between the five-factor model of personality and symptoms of clinical disorders: A meta-analysis. J Psychopathol Behav Assess. 2005;27(2):101–14.

    Article  Google Scholar 

  14. Costa PTJ, McCrae RR. Revised NEO Personality Inventory (NEO-PI-R) and NEO Five-Factor Inventory (NEO-FFI) professional manual. Odessa, FL: Psychological Assessment Resources; 1992.

    Google Scholar 

  15. Al-Omiri MK, Alzoubi IA, Al Nazeh AA, Alomiri AK, Maswady MN, Lynch E. COVID-19 and personality: A cross-sectional multicenter study of the relationship between personality factors and COVID-19-related impacts, concerns, and behaviors. Front Psychiatry. 2021;12:608730.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Gubler DA, Makowski LM, Troche SJ, Schlegel K. Loneliness and well-being during the Covid-19 pandemic: Associations with personality and emotion regulation. J Happiness Stud. 2021;22(5):2323–42.

    Article  PubMed  Google Scholar 

  17. Zettler I, Schild C, Lilleholt L, Kroencke L, Utesch T, Moshagen M, et al. The Role of Personality in COVID-19-Related Perceptions, Evaluations, and Behaviors: Findings Across Five Samples. Nine Traits, and 17 Criteria Soc Psychol Personal Sci. 2020;19485506211001680.

  18. Nikčević AV, Marino C, Kolubinski DC, Leach D, Spada MM. Modelling the contribution of the Big Five personality traits, health anxiety, and COVID-19 psychological distress to generalised anxiety and depressive symptoms during the COVID-19 pandemic. J Affect Disord. 2021;279:578–84.

    CAS  Article  PubMed  Google Scholar 

  19. Shokrkon A, Nicoladis E. How personality traits of neuroticism and extroversion predict the effects of the COVID-19 on the mental health of Canadians. PLoS One. 2021;16(5):e0251097.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  20. Kroencke L, Geukes K, Utesch T, Kuper N, Back M. Neuroticism and emotional risk during the COVID-19 pandemic. J Res Pers. 2020;89:104038.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  21. Fergus S, Zimmerman MA. Adolescent resilience: A framework for understanding healthy development in the face of risk. Annu Rev Public Health. 2005;26:399–419.

    Article  PubMed  Google Scholar 

  22. Oshio A, Taku K, Hirano M, Saeed G. Resilience and Big Five personality traits: A meta-analysis. Pers Individ Differ. 2018;127:54–60.

    Article  Google Scholar 

  23. Friborg O, Barlaug D, Martinussen M, Rosenvinge JH, Hjemdal O. Resilience in relation to personality and intelligence. Int J Methods Psychiatr Res. 2005;14(1):29–42.

    Article  PubMed  Google Scholar 

  24. Gramzow RH, Sedikides C, Panter A, Sathy V, Harris J, Insko CA. Patterns of self-regulation and the Big Five. Eur J Personal. 2004;18(5):367–85.

    Article  Google Scholar 

  25. Kendler KS, Gardner CO, Prescott CA. Personality and the experience of environmental adversity. Psychol Med. 2003;33(7):1193–202.

    CAS  Article  PubMed  Google Scholar 

  26. Magnus K, Diener E, Fujita F, Pavot W. Extraversion and neuroticism as predictors of objective life events: a longitudinal analysis. J Pers Soc Psychol. 1993;65(5):1046.

    CAS  Article  PubMed  Google Scholar 

  27. Havnen A, Anyan F, Hjemdal O, Solem S, Gurigard Riksfjord M, Hagen K. Resilience moderates negative outcome from stress during the COVID-19 pandemic: A moderated-mediation approach. Int J Environ Res Public Health. 2020;17(18):6461.

    CAS  Article  PubMed Central  Google Scholar 

  28. Bonanno GA. Loss, trauma, and human resilience: Have we underestimated the human capacity to thrive after extremely aversive events? Am Psychol. 2004;59(1):20–8.

    Article  PubMed  Google Scholar 

  29. Luthar SS, Cicchetti D, Becker B. The construct of resilience: A critical evaluation and guidelines for future work. Child Dev. 2000;71(3):543–62.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  30. Masten AS, Best KM, Garmezy N. Resilience and development: Contributions from the study of children who overcome adversity. Dev Psychopathol. 1990;2(4):425–44.

    Article  Google Scholar 

  31. Kobasa SC. Stressful life events, personality, and health: an inquiry into hardiness. J Pers Soc Psychol. 1979;37(1):1–11.

    CAS  Article  PubMed  Google Scholar 

  32. Bartone PT. Resilience under military operational stress: Can leaders influence hardiness? Mil Psychol. 2006;18:131–48.

    Article  Google Scholar 

  33. Hystad SW, Eid J, Johnsen BH, Laberg JC, Thomas BP. Psychometric properties of the revised Norwegian dispositional resilience (hardiness) scale. Scand J Psychol. 2010;51(3):237–45.

    Article  PubMed  Google Scholar 

  34. Kobasa SC, Maddi SR, Zola MA. Type A and hardiness. J Behav Med. 1983;6(1):41–51.

    CAS  Article  PubMed  Google Scholar 

  35. Bartone PT. Test-retest reliability of the dispositional resilience scale-15, a brief hardiness scale. Psychol Rep. 2007;101(3):943–4.

    Article  PubMed  Google Scholar 

  36. Bartone PT, Homish GG. Influence of hardiness, avoidance coping, and combat exposure on depression in returning war veterans: A moderated-mediation study. J Affect Disord. 2020;265:511–8.

    Article  PubMed  Google Scholar 

  37. Escolas SM, Pitts BL, Safer MA, Bartone PT. The protective value of hardiness on military posttraumatic stress symptoms. Mil Psychol. 2013;25(2):116–23.

    Article  Google Scholar 

  38. Hystad SW, Eid J, Laberg JC, Johnsen BH, Bartone PT. Academic stress and health: Exploring the moderating role of personality hardiness. Scand J Educ Res. 2009;53(5):421–9.

    Article  Google Scholar 

  39. Bandura A. Self-efficacy mechanism in human agency. Am Psychol. 1982;37(2):122–47.

    Article  Google Scholar 

  40. Eschleman KJ, Bowling NA, Alarcon GM. A meta-analytic examination of hardiness. Int J Stress Manag. 2010;17(4):277–307.

    Article  Google Scholar 

  41. Taft CT, Stern AS, King LA, King DW. Modeling physical health and functional health status: The role of combat exposure, posttraumatic stress disorder, and personal resource attributes. J Trauma Stress. 1999;12(1):3–23.

    CAS  Article  PubMed  Google Scholar 

  42. Vagni M, Maiorano T, Giostra V, Pajardi D. Hardiness, stress and secondary trauma in Italian healthcare and emergency workers during the COVID-19 pandemic. Sustainability. 2020;12(14):5592.

    CAS  Article  Google Scholar 

  43. The Take.Care2020-project. Accessed 23 January 2022.

  44. Unnarsdóttir AB, Lovik A, Fawns-Ritchie C, Ask H, Kõiv K, Hagen K, et al. Cohort Profile: COVIDMENT: COVID-19 cohorts on mental health across six nations. Int J Epidemiol. 2021.

  45. Schafer JL. Multiple imputation: a primer. Stat Methods Med Res. 1999;8(1):3–15.

    CAS  Article  PubMed  Google Scholar 

  46. Gosling SD, Rentfrow PJ, Swann WB Jr. A very brief measure of the Big-Five personality domains. J Res Pers. 2003;37(6):504–28.

    Article  Google Scholar 

  47. Romero E, Villar P, Gómez-Fraguela JA, López-Romero L. Measuring personality traits with ultra-short scales: A study of the Ten Item Personality Inventory (TIPI) in a Spanish sample. Pers Individ Differ. 2012;53(3):289–93.

    Article  Google Scholar 

  48. Muck PM, Hell B, Gosling SD. The construct validation of a short five- factor model instrument: A self-peer study on the German adaptation of the Ten-Item Personality Inventory (TIPI-G). Eur J Psychol Assess. 2007;23(3):166–75.

    Article  Google Scholar 

  49. Kroenke K, Wu J, Yu Z, Bair MJ, Kean J, Stump T, et al. The patient health questionnaire anxiety and depression scale (PHQ-ADS): Initial validation in three clinical trials. Psychosom Med. 2016;78(6):716–27.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–13.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  51. Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–7.

    Article  PubMed  Google Scholar 

  52. Kroenke K, Baye F, Lourens SG. Comparative validity and responsiveness of PHQ-ADS and other composite anxiety-depression measures. J Affect Disord. 2019;246:437–43.

    Article  PubMed  Google Scholar 

  53. Cohen J, Cohen P, West SG, Aiken LS. Applied multiple regression and correlation for the behavioral sciences. 3rd ed. Mahwah, NJ: Lawrence Erlbaum Associates; 2003.

    Google Scholar 

  54. Roelofs J, Huibers M, Peeters F, Arntz A. Effects of neuroticism on depression and anxiety: Rumination as a possible mediator. Pers Individ Differ. 2008;44(3):576–86.

    Article  Google Scholar 

  55. Roelofs J, Huibers M, Peeters F, Arntz A, van Os J. Rumination and worrying as possible mediators in the relation between neuroticism and symptoms of depression and anxiety in clinically depressed individuals. Behav Res Ther. 2008;46(12):1283–9.

    Article  PubMed  Google Scholar 

  56. Wells A. Metacognitive Therapy for Anxiety and Depression. New York, NY: Guildford press; 2009.

    Google Scholar 

  57. Hong RY, Cheung MW-L. The structure of cognitive vulnerabilities to depression and anxiety: Evidence for a common core etiologic process based on a meta-analytic review. Clin. Psychol Sci. 2015;3(6):892–912.

    Article  Google Scholar 

  58. Brand JE. The far-reaching impact of job loss and unemployment. Annu Rev Sociol. 2015;41:359–75.

    Article  PubMed  PubMed Central  Google Scholar 

  59. NICE. (National Institute for Health and Care Excellence). Depression in adults: treatment and management, vol. NG222; 2022.

    Google Scholar 

  60. NICE. (National Institute for Health and Care Excellence). Generalised anxiety disorder and panic disorder in adults: management; 2011. p. CG113.

    Google Scholar 

Download references


We would like to thank the participants for their contribution to the current study.


N/A. The study was conducted without external funding.

Author information

Authors and Affiliations



KH, GK, JE, and SLH are responsible for the BryDeg2020-project and obtained ethical approval. Conceptualization and design of this paper: ERL and SS; Data preparation and formal analysis: ERL and SS; Writing original draft: ERL; Rewriting and editing: ERL, SS, KH, GK, JE and SLH. All authors have read and agreed to the published version of the manuscript.

Corresponding author

Correspondence to Espen Rasmussen Lassen.

Ethics declarations

Ethics approval and consent to participate

The study obtained ethical approval from the Regional Committee for Medical and Health Research Ethics in Northern Norway (REK Nord, reference number 123324). Written informed consent was obtained from all participants before inclusion. The entire study was carried out in accordance with the Declaration of Helsinki and obtained ethical approval from the appropriate ethics committee (REK Nord).

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Lassen, E.R., Hagen, K., Kvale, G. et al. Personality traits and hardiness as risk- and protective factors for mental distress during the COVID-19 pandemic: a Norwegian two-wave study. BMC Psychiatry 22, 610 (2022).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI:


  • Personality traits
  • Hardiness
  • Anxiety
  • Depression
  • COVID-19 pandemic